UnknownNot Applicable

Prediction of Late Fetal Growth Restriction Using Cerebroplacental Ratio

Egypt200 participantsStarted 2021-02-01

Plain-language summary

To investigate the screening performance of CPR and biophysical profile score for the prediction of composite of adverse neonatal morbidity and mortality and operative delivery (CS or instrumental) for intrapartum fetal distress in low-risk pregnancies

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * •Women with uncomplicated singleton pregnancy who are planning a vaginal delivery * Gestational age from 36 ± 0/7 weeks until onset of active labor (cervical dilatation ≤ 4cm) * Cephalic presentation Exclusion Criteria: * •Multiple pregnancy * known SGA fetus. * Medical disorders with pregnancy: diabetes mellitus, hypertension, pre-eclampsia * Known fetal anomaly or aneuploidy or stillbirth. * Any contraindication of vaginal delivery eg. placenta previa.

What they're measuring

A composite of adverse neonatal outcomes

Timeframe: Up to 48 hours After delivery

Trial details

NCT IDNCT04640467

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10-01

Contact for this trial

Mariam Sobhy, MBBCH

+201095811120 rrrrgds83@gmail.com

View on ClinicalTrials.gov More Fetal Growth Retardation trials